These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. van Royen E; Verhoeff NF; Speelman JD; Wolters EC; Kuiper MA; Janssen AG Arch Neurol; 1993 May; 50(5):513-6. PubMed ID: 8489409 [TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand. de Herder WW; Reijs AE; Kwekkeboom DJ; Hofland LJ; Nobels FR; Oei HY; Krenning EP; Lamberts SW Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343 [TBL] [Abstract][Full Text] [Related]
10. [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy. Schwarz J; Tatsch K; Gasser T; Arnold G; Oertel WH Mov Disord; 1997 Nov; 12(6):898-902. PubMed ID: 9399212 [TBL] [Abstract][Full Text] [Related]
11. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Eisensehr I; Linke R; Noachtar S; Schwarz J; Gildehaus FJ; Tatsch K Brain; 2000 Jun; 123 ( Pt 6)():1155-60. PubMed ID: 10825354 [TBL] [Abstract][Full Text] [Related]
12. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography. Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673 [TBL] [Abstract][Full Text] [Related]
13. D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status. Schlösser R; Schlegel S J Neural Transm Gen Sect; 1995; 99(1-3):173-85. PubMed ID: 8579803 [TBL] [Abstract][Full Text] [Related]
14. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties]. Matsumura K; Toyama H; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors. Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain. Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302 [TBL] [Abstract][Full Text] [Related]
17. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]. Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843 [TBL] [Abstract][Full Text] [Related]
18. Iodine-123-iodobenzamide binding in parkinsonism: reduction by dopamine agonists but not L-Dopa. Schwarz J; Oertel WH; Tatsch K J Nucl Med; 1996 Jul; 37(7):1112-5. PubMed ID: 8965179 [TBL] [Abstract][Full Text] [Related]
19. Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study. Pizzolato G; Chierichetti F; Rossato A; Cagnin A; Fabbri M; Dam M; Ferlin G; Battistin L J Neural Transm Suppl; 1995; 45():113-22. PubMed ID: 8748616 [TBL] [Abstract][Full Text] [Related]
20. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study. Bigliani V; Mulligan RS; Acton PD; Ohlsen RI; Pike VW; Ell PJ; Gacinovic S; Kerwin RW; Pilowsky LS Psychopharmacology (Berl); 2000 Jun; 150(2):132-40. PubMed ID: 10907666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]